It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 0.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...

Inogen's new management and strategy are yielding results, with better-than-expected 2024 performance and a more stable base from which to keep growing the B2B business. Despite weak DTC sales, strong ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of its high prospects in the portable oxygen concentrator (POC) space. The optimism led by solid second-quarter 2023 and a ...

Inogen, Inc. INGN incurred an adjusted loss per share of 2 cents for second-quarter 2025, which was narrower than the adjusted loss per share of 7 cents in the year-ago period and the Zacks Consensus ...

Inogen Inc (NASDAQ:INGN), a medical technology company, reported fourth-quarter 2023 revenues of $75.90 million, missing the consensus of $76.99 million. Fourth quarter total revenue fell from $88.1 ...

* Inogen-On Dec 1, board appointed Scott Wilkinson, currently co's president and chief operating officer, to serve as president, CEO of co- sec filing Sign up here. * Inogen Inc- Wilkinson will ...